Everence Capital Management’s Usana Health Sciences USNA Stock Holding History

Everence Capital Management’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,410	Closed	-$244K	–	783
2021 Q4	$244K	Hold	2,410	–	–	0.02%	666
2021 Q3	$222K	Hold	2,410	–	–	0.02%	662
2021 Q2	$247K	Hold	2,410	–	–	0.02%	622
2021 Q1	$235K	Buy	+2,410	New	+$219K	0.02%	639
2020 Q3	–	Sell	-2,410	Closed	-$204K	–	746
2020 Q2	$204K	Buy	+2,410	New	+$189K	0.02%	579

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Everence Capital Management's USNA Position: Q1 2022 in Review

Everence Capital Management sold out of Usana Health Sciences (USNA) in Q1 2022, closing a stake of 2,410 shares — an estimated $244K sold.

Everence Capital Management first reported a position in USNA in Q2 2020 and held it in 5 quarters. The position peaked at $247K in Q2 2021. 179 funds tracked by Wall St. Rank hold USNA as of Q1 2022.

Everence Capital Management reported no remaining Usana Health Sciences position as of Q1 2022 after selling out during the quarter.
Everence Capital Management sold 2,410 Usana Health Sciences shares in Q1 2022, an estimated $244K.
Everence Capital Management first reported a position in Usana Health Sciences in Q2 2020 and held it in 5 quarters.
Everence Capital Management's Usana Health Sciences position peaked at $247K in Q2 2021.
179 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2022.

Based on Everence Capital Management's 13F filing for Q1 2022, filed 11 Apr 2022.